3108-15-4 Usage
General Description
2,5-dimethoxybenzenediazonium tetrafluoroborate is a chemical compound that is commonly used in the synthesis of various organic compounds. It is a diazonium salt, which means it contains a nitrogen-nitrogen triple bond and is formed by the reaction of an aromatic amine with nitrous acid. 2,5-dimethoxybenzenediazonium tetrafluoroborate is often used as a source of the diazonium ion, which can undergo a variety of reactions to produce new carbon-carbon or carbon-heteroatom bonds. The tetrafluoroborate counterion helps to stabilize the diazonium ion and make it more suitable for use in synthetic chemistry. Overall, 2,5-dimethoxybenzenediazonium tetrafluoroborate is an important reagent in the toolbox of organic chemists for creating diverse and interesting molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 3108-15-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,1,0 and 8 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 3108-15:
(6*3)+(5*1)+(4*0)+(3*8)+(2*1)+(1*5)=54
54 % 10 = 4
So 3108-15-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H9N2O2.BF4/c1-11-6-3-4-8(12-2)7(5-6)10-9;2-1(3,4)5/h3-5H,1-2H3;/q+1;-1
3108-15-4Relevant articles and documents
Direct and Versatile Synthesis of Red-Shifted Azobenzenes
Hansen, Mickel J.,Lerch, Michael M.,Szymanski, Wiktor,Feringa, Ben L.
supporting information, p. 13514 - 13518 (2016/10/21)
A straightforward synthesis of azobenzenes with bathochromically-shifted absorption bands is presented. It employs an ortho-lithiation of aromatic substrates, followed by a coupling reaction with aryldiazonium salts. The products are obtained with good to excellent yields after simple purification. Moreover, with the presented methodology, a structurally diverse panel of different azobenzenes, including unsymmetric tetra-ortho-substituted ones, can be readily obtained, which paves the way for future development of red-light-addressable azobenzene derivatives for in vivo application.
